Research News and Research

RSS

Insurer to take new role in assessing cancer treatments

UnitedHealthcare, one of the nation's biggest insurance companies, has decided to take a more active role in the care of its policy holders who are being treated for several types of cancer, The Wall Street Journal reports.

9 Feb 2010

GOP wary of talks while both sides express low expectations for health care summit

News outlets are focusing on political reaction to President Obama's Feb. 25 bipartisan summit on health care reform.

9 Feb 2010

FDA grants marketing clearance for Volcano's Eagle Eye Platinum digital IVUS catheter

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States.

9 Feb 2010

CQ examines concerns over Obama's FY2011 global health budget

Congressional Quarterly examines concerns among health advocates and international development experts about what President Obama's FY 2011 budget request might mean to U.S. commitments to particular diseases abroad, such as HIV/AIDS, tuberculosis and malaria.

9 Feb 2010

Faced with stalled overhaul, Dems still wonder who to blame

Congressional Democrats continue to divvy up blame for the stalled health overhaul, with fingers now pointed toward centrist Democrats and Republicans, President Barack Obama or even White House Chief of Staff Rahm Emanuel, depending on the blamer's perspective.

9 Feb 2010

SIRO Clinpharm announces alliance with DreamCIS CRO

SIRO Clinpharm, a Contract Research Organization (CRO) with a presence in India, Western and Central Eastern Europe, and the United States today announced its alliance with DreamCIS Inc., a leading CRO based in Seoul, South Korea.

9 Feb 2010

Surgical 'checklist' saves money, lives

The Newshour has a transcript of a feature report on Dr. Atul Gawande's new book, "The Checklist Manifesto: How to Get Things Right," which "grew out of work he did for the World Health Organization, which asked him to help them find a way to reduce deaths in surgery."

9 Feb 2010

As health overhaul stalls, hospitals face rising cost of uncompensated care

For American hospitals, "the cost of doing nothing in Washington translates into tens of billions of dollars each year in medical bills that go unpaid by patients with little or no insurance," The New York Times reports.

9 Feb 2010

2010 HSR Impact Award recognizes research that improves patient safety and surgical outcomes

AcademyHealth today recognized research that improves patient safety and surgical outcomes with the 2010 Health Services Research (HSR) Impact Award. The WHO Surgical Safety Checklist was created as a tool to ensure adherence to basic safety standards of care.

9 Feb 2010

For senior care, sometimes it does take a village

In an article for Kaiser Health News and The Washington Post, Howard Gleckman writes about elder villages. "Nearly three years ago, Harry Rosenberg and his wife, Barbara Filner, met with nine of their neighbors about starting an aging-in-place "village" in the Burning Tree community of Bethesda, Maryland.

9 Feb 2010

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.

9 Feb 2010

Whooping cough vaccine may be losing its punch: study

Vaccination programs against whooping cough may not be fully effective because the bacteria that cause the disease have evolved new strains, a new study has found.

9 Feb 2010

Morphologi G3 adds new dimension to Solvay Pharmaceuticals R&D

Solvay Pharmaceuticals Inc. (Marietta, GA, USA) was the first company in the United States to install the innovative Morphologi G3 image analysis-based particle characterization system from Malvern Panalytical.

From Malvern Panalytical 9 Feb 2010

Health debate travails boost lobbying firms

Sen. Scott Brown, R-Mass., won an upset election last month that has reshaped the health debate and that new dynamic could be a boon for lobbying firms, The Philadelphia Inquirer's Law Review columnist writes. "The thousands of lobbyists on and off Capitol Hill who labor on behalf of health-industry clients can now count on at least a few more monthly retainers.

9 Feb 2010

Simple, inexpensive test for diagnosing cardiac-related chest pain

Researchers at the Methodist DeBakey Heart & Vascular Center have shown that a simple, inexpensive test can determine whether it is safe to send home a patient who comes to the emergency room with chest pain.

9 Feb 2010

Chi-Fu Trading to market and sell Delcath PHP Systems in Taiwan

Delcath Systems, Inc. (DCTH), a medical technology company testing its proprietary treatment system for primary and metastatic cancers to the liver, announced today the signing of its first research, distribution, sales and marketing agreement for its Percutaneous Hepatic Perfusion (PHP) System (the Delcath PHP System™). The agreement grants Chi-Fu Trading Co., Ltd. the exclusive right to market and sell the Delcath PHP System in Taiwan for hepatic malignancies and infectious disease upon Taiwan Food and Drug Administration (TFDA) approval, and any other approved use, with a conditional option for Singapore.

9 Feb 2010

Egg consumption does not raise blood cholesterol

February is American Heart Month, which means it's time to raise awareness about cardiovascular disease, the leading cause of death in America.

9 Feb 2010

Biogen Idec reports 2009 fourth quarter and full year earnings

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2009 results.

9 Feb 2010

Fourth-quarter and full-year 2009 results announced by Compugen

Compugen Ltd. today reported financial results for the fourth quarter and year ending December 31, 2009.

9 Feb 2010

Third-quarter fiscal 2010 results announced by Clinical Data

Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company’s operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.

9 Feb 2010